Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit
Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit
Click here to reserve your seat Fireside Chat Scheduled for 2:00 PM ET on October 15, 2024
2024年10月15日美东时间下午2点举行的炉边聊天
BROOMFIELD, Colo., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today that Aclarion's CEO, Brent Ness, has been invited to present at the 2024 Maxim Healthcare Virtual Summit, presented by Maxim Group LLC, on Tuesday, October 15 th , 2024, at 2:00 p.m. E.T.
科罗拉多州布鲁姆菲尔德，2024年10月10日（环球新闻社） - 健康科技公司Aclarion, Inc。（"Aclarion" 或 "公司"）（纳斯达克股票代码: ACON, ACONW），利用生物标志物和专有的增强智能（AI）算法帮助医生识别慢性腰痛的位置的健康科技公司Aclarion今天宣布，Aclarion首席执行官布伦特·尼斯已受邀在2024年由Maxim Group LLC主办的Maxim Healthcare虚拟峰会上演讲，演讲时间为2024年10月15日星期二下午2点美东时间
Maxim senior analysts will host a wide range of biotechnology, diagnostic, medical device, and healthcare information technology companies in a series of presentations and interactive discussions with CEOs and key management.
Maxim资深分析师将邀请各种生物技术、诊断、医疗器械和医疗信息技术公司进行一系列演讲和与首席执行官及关键管理人员的互动讨论
Click here to reserve your seat
点击这里预留您的座位
About Aclarion, Inc.
关于Aclarion, Inc.
Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy ("MRS"), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies. For more information, please visit .
Aclarion是一家利用磁共振波谱学（"MRS"）、专有信号处理技术、生物标志物和增强智能算法来优化临床治疗的健康科技公司。该公司首次通过Nociscan进入慢性腰痛市场，这是第一个经证据支持的saas-云计算平台，用于非侵入性地帮助医生区分腰椎间盘的疼痛与非疼痛。通过云连接，Nociscan接收每个腰椎盘的磁共振波谱学（MRS）数据。在云端，专有的信号处理技术提取和量化与盘痛有关的化学生物标志物。生物标志物数据被输入专有算法以指示盘可能是疼痛源。当与其他诊断工具一起使用时，Nociscan提供对患者腰痛位置的关键洞察，使医生能够优化治疗策略。欲了解更多信息，请访问
Investor Contacts:
Kirin M. Smith
PCG Advisory, Inc.
646.823.8656
ksmith@pcgadvisory.com
投资者联系人：查看更多信息前往：
Kirin m. Smith
PCG Advisory, Inc.
646.823.8656
ksmith@pcgadvisory.com
Media Contacts:
Jodi Lamberti
SPRIG Consulting
612.812.7477
jodi@sprigconsulting.com
媒体联系人：
Jodi Lamberti
SPRIG咨询公司
612.812.7477
jodi@sprigconsulting.com
